Pamifos (Pamidronate Disodium)

Pamidronate disodium, the active ingredient in Pamifos, is a bisphosphonate presented as a sterile injectable solution for intravenous use. It is used to manage bone disorders such as hypercalcemia of malignancy, Paget's disease, and to prevent skeletal complications in patients with bone metastases.

GNH USA supplies Pamifos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Pamifos is a bisphosphonate that acts on disorders of bone metabolism. - Hypercalcemia of malignancy: helps reduce the elevated calcium levels associated with cancer. - Paget’s disease of bone: slows the abnormal bone remodeling process and reduces bone pain. - Bone metastases: lowers the risk of skeletal‑related events such as pathological fractures. - Osteoporosis (off‑label use): may increase bone mineral density, though it is not the primary approved indication.

Side effects of pam ... Common Side Effects: -  ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  ... ...  ...  ... ... ... ... ... ... ... ... ... ... ... ... ... Serious or Rare ... ... ...... ... ... ... ... ... ...